axitinib
Axitinib is an indazole derivative. It is most commonly marketed under the name Inlyta® and is available in oral formulations._x000D_ Axitinib is a second generation tyrosine kinase inhibitor that works by selectively inhibiting vascular endothelial growth factor receptors (VEGFR-1, VEGFR-2, VEGFR-3).7. Reference standards of Axitinib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => 6-Iodo-1H-indazole
[catalogue_number] => PA 28 45650
[category_ids] => ,79,80,71,84,
[chemical_name] =>
[weight] => 244.03
[form] => C7H5IN2
[cas] => 261953-36-0
[pslug] => 261953-36-0-6-iodo-1h-indazole-pa2845650
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Catalogue No.:PA 28 45650
Molecular Formula : C7H5IN2
Molecular Weight : 244.03
stdClass Object
(
[pname] => 3,6-Diiodo-1H-indazole
[catalogue_number] => PA 28 45660
[category_ids] => ,79,80,71,84,
[chemical_name] =>
[weight] => 369.93
[form] => C7H4I2N2
[cas] => 319472-78-1
[pslug] => 319472-78-1-3-6-diiodo-1h-indazole-pa2845660
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Catalogue No.:PA 28 45660
Molecular Formula : C7H4I2N2
Molecular Weight : 369.93